Article info

Download PDFPDF
Experimental therapeutics—preclinical
P01 Antisense oligonucleotide mediated transcript reduction and modulation—the European approach to develop a therapy for Huntington disease

Authors

Citation

van Roon-Mom W, Evers M, Tran H, et al
P01 Antisense oligonucleotide mediated transcript reduction and modulation—the European approach to develop a therapy for Huntington disease

Publication history

  • First published August 29, 2012.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.